
Cell MedX Corp.
Share · US15115X1072 (OTC)
No Price
n/a
Company Profile for Cell MedX Corp. Share
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.
Company Data
Name Cell MedX Corp.
Company Cell MedX Corp.
Website
https://www.cellmedx.com
Primary Exchange
UTC
ISIN US15115X1072
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO David M. Jeffs
Market Capitalization 126 Mio
Country United States of America
Currency USD
Employees -
Address 123 West Nye Ln, 89706 Carson City
IPO Date 2013-08-29
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | CMXC |
More Shares
Investors who hold Cell MedX Corp. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



